Altrafin AG’s Vertiv VRT Stock Holding History

Altrafin AG’s Portfolio VRT Stock Details VRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.55M	Sell	4,625 -4,581	-50%	-$1.45M	0.61%	34
2026 Q1	$2.31M	Buy	+9,206	New	+$2.04M	0.8%	29

Other funds holding VRT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Altrafin AG's VRT Position: Q2 2026 in Review

Altrafin AG reduced its Vertiv (VRT) stake by 50% in Q2 2026, selling an estimated $1.45M and leaving 4,625 shares worth $1.55M. The position accounts for 0.61% of the portfolio, ranked #34.

Altrafin AG first reported a position in VRT in Q1 2026 and has held it in 2 quarters since. The position peaked at $2.31M in Q1 2026. 2,045 funds tracked by Wall St. Rank hold VRT as of Q2 2026.

Altrafin AG held 4,625 shares of Vertiv worth $1.55M as of Q2 2026.
Altrafin AG sold 4,581 Vertiv shares in Q2 2026, an estimated $1.45M.
Vertiv made up 0.61% of Altrafin AG's portfolio in Q2 2026, its #34 holding.
Altrafin AG first reported a position in Vertiv in Q1 2026 and has held it in 2 quarters since.
Altrafin AG's Vertiv position peaked at $2.31M in Q1 2026.
2,045 funds tracked by Wall St. Rank held Vertiv as of Q2 2026.

Based on Altrafin AG's 13F filing for Q2 2026, filed 15 Jul 2026.